[
  {
    "trial_id": "NCT00109785",
    "mcode_mappings": [
      {
        "resourceType": "CancerCondition",
        "clinicalStatus": "active",
        "verificationStatus": "confirmed",
        "code": {
          "coding": [
            {"system": "http://snomed.info/sct", "code": "254837009", "display": "Locally Advanced Breast Cancer"}
          ]
        },
        "subject": {"reference": "Patient/1"},
        "onsetDateTime": "1997-03"
      },
      {
        "resourceType": "ImagingTest",
        "testType": "PET scan (IUdR, FDG)",
        "method": "IUdR PET, FDG PET",
        "result": "Pre- and post-chemotherapy tumor activity and metabolic change",
        "date": "1997-03"
      },
      {
        "resourceType": "Treatment",
        "treatmentType": "Chemotherapy, Surgery, Radiation Therapy",
        "agents": ["Chemotherapy (varied)", "Surgical resection", "Radiation therapy"],
        "arm": "PET Scans",
        "startDate": "1997-03",
        "endDate": "2008-12"
      },
      {
        "resourceType": "Outcome",
        "primaryOutcome": "Tumor metabolic activity and response to chemotherapy",
        "secondaryOutcomes": ["Tumor shrinkage", "DNA incorporation of IUdR", "Comparison of FDG and IUdR PET results", "Metabolic changes in metastatic sites"],
        "resultSummary": "PET scans used to monitor chemotherapy effectiveness and tumor metabolism in locally advanced breast cancer."
      }
    ],
    "source_text_fragment": "PET Scans in Patients With Locally Advanced Breast Cancer. Study of I-124-Iododeoxyuridine and FDG PET scans to monitor DNA metabolism and glycolysis in tumor samples before and after chemotherapy."
  }
]
